Literature DB >> 8403256

Use-dependent block and use-dependent unblock of the delayed rectifier K+ current by almokalant in rabbit ventricular myocytes.

E Carmeliet1.   

Abstract

A voltage-clamp analysis of the effect of almokalant on the delayed rectifier K+ current (IK) was made in rabbit ventricular myocytes. The two-suction pipette method was used, and appropriate voltage-clamp protocols were used to study more specifically use dependence, block development, and recovery from block. Almokalant interacted with the IK in two ways: it shifted the activation curve in the hyperpolarizing direction (stimulatory effect) and blocked the open IK channel in a use-dependent way (inhibitory effect). For 2-second voltage clamps to +20 mV, half-maximum block was obtained at 5 x 10(-8) mol/L, with a Hill coefficient of 1.76. Use-dependent block was related to an open-channel block that occurred at 0 mV with a time constant of 1.07 second and a rather slow recovery from block: at -50 mV, recovery time constant was approximately 10 seconds; at -75 mV, recovery was practically absent. The absence of an important recovery at negative membrane potentials is consistent with the hypothesis of the drug being trapped in the channel. A limited frequency-dependent block could be demonstrated. Use-dependent unblock was demonstrated by a rapid recovery from block during stimulation following complete washout of the drug. It is concluded that almokalant shifts the activation curve of IK in the hyperpolarizing direction, blocks the open channel, and is trapped by the closure of the activation gate.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8403256     DOI: 10.1161/01.res.73.5.857

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  22 in total

Review 1.  Antiarrhythmics--from cell to clinic: past, present, and future.

Authors:  J C Hancox; K C Patel; J V Jones
Journal:  Heart       Date:  2000-07       Impact factor: 5.994

Review 2.  Drug binding to HERG channels: evidence for a 'non-aromatic' binding site for fluvoxamine.

Authors:  John S Mitcheson
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

Review 3.  Revealing the structural basis of action of hERG potassium channel activators and blockers.

Authors:  Matthew Perry; Michael Sanguinetti; John Mitcheson
Journal:  J Physiol       Date:  2010-07-19       Impact factor: 5.182

4.  Probing the mechanisms underlying modulation of quinidine sensitivity to cardiac I(Ks) block by protein kinase A-mediated I(Ks) phosphorylation.

Authors:  Tao Yang; Hideaki Kanki; Wei Zhang; Dan M Roden
Journal:  Br J Pharmacol       Date:  2009-06-12       Impact factor: 8.739

5.  A quantitative analysis of the activation and inactivation kinetics of HERG expressed in Xenopus oocytes.

Authors:  S Wang; S Liu; M J Morales; H C Strauss; R L Rasmusson
Journal:  J Physiol       Date:  1997-07-01       Impact factor: 5.182

6.  Assessment of frequency dependency of the class III effects of almokalant: a study using programmed stimulation and recording of monophasic action potentials and ventricular paced QT intervals.

Authors:  B Darpö; O Almgren; R Bergstrand; S Franzén; N Edvardsson
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

7.  Mechanisms of block of a human cloned potassium channel by the enantiomers of a new bradycardic agent: S-16257-2 and S-16260-2.

Authors:  E Delpón; C Valenzuela; O Pérez; L Franqueza; P Gay; D J Snyders; J Tamargo
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

8.  A quantitative description of the E-4031-sensitive repolarization current in rabbit ventricular myocytes.

Authors:  J R Clay; A Ogbaghebriel; T Paquette; B I Sasyniuk; A Shrier
Journal:  Biophys J       Date:  1995-11       Impact factor: 4.033

9.  Mechanism of HERG potassium channel inhibition by tetra-n-octylammonium bromide and benzethonium chloride.

Authors:  Yan Long; Zuoxian Lin; Menghang Xia; Wei Zheng; Zhiyuan Li
Journal:  Toxicol Appl Pharmacol       Date:  2013-01-08       Impact factor: 4.219

10.  Stereoselective block of a human cardiac potassium channel (Kv1.5) by bupivacaine enantiomers.

Authors:  C Valenzuela; E Delpón; M M Tamkun; J Tamargo; D J Snyders
Journal:  Biophys J       Date:  1995-08       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.